Publications by authors named "Troy K Belcher"
J Pharmacol Sci
March 2017
Article Synopsis
- FTY720 is a drug originally used to treat multiple sclerosis, and it helps increase levels of a neuroprotective factor called BDNF in the brain.
- Preclinical studies indicate that FTY720 may also have benefits for Parkinson's patients, though its immunosuppressive properties could limit its use.
- Two new versions of FTY720, named FTY720-C2 and FTY720-Mitoxy, show promise for stimulating BDNF without causing the same immunosuppressive effects, making them candidates for further testing as potential treatments for Parkinson's disease.
